SDTMA 2020-2023 Fentanyl Pill Analysis Report

[Marla Kingkade]

I apologize I did not attached the 2020 – 2023 Fentanyl Pills Analysis Report.  Again, this email is being sent on behalf of David King, Executive Directive, San Diego Imperial HIDTA.

Thank you,

Marla Kingkade
San Diego County Substance Use and Overdose Prevention Taskforce
Center for Community Research
8885 Rio San Diego Drive, Suite 335
San Diego, California, 92108
 [cid:image003.png at 01DABE3A.86BA2E20]
Confidentiality Notice. This email message, including any attachments, is only for the intended recipient(s). This email and any attachments may contain information that is confidential, legally privileged, or otherwise protected or exempt from disclosure under applicable law. If you are not a named recipient, or if you are named but believe that you received this email in error, please notify the sender immdiately by telephone or return email and promptly delete this email and any attachments and copies thereof from your system. Any copying, distribution, dissemination, disclosure, or taking of any action in reliance on the contents of this transmission, by someone other than the intended addressee or its authorized agent is strictly unauthorized and prohibited. If you are not the intended recipient, any copying, distribution, dissemination, disclosure, or other use of this email and any attachments is unauthorized and prohibited. Your receipt of this message is not intended to waive any applicable privilege or claim of confidentiality. Thank you for your cooperation.

I wanted to forward this seizure data from the HIDTA Drug Threat Analysis Group (DTAG)

Thank you for the continued support,

David King, Executive Director
San Diego Imperial Valley HIDTA
Cell: (858) 248-2252
david.king at sdi.hidta.org<mailto:david.king at sdi.hidta.org>


[Logo  Description automatically generated][Logo  Description automatically generated]

From: Hamby, David <DHamby at achidta.org<mailto:DHamby at achidta.org>>
Sent: Monday, June 10, 2024 1:14 PM
To: King, David <David.King at sdi.hidta.org<mailto:David.King at sdi.hidta.org>>
Cc: Partridge, Ralph <Ralph.Partridge at sdi.hidta.org<mailto:Ralph.Partridge at sdi.hidta.org>>
Subject: 2020-2023 Fentanyl Pill Analysis Report

CAUTION: This email was received from an EXTERNAL source, use caution when clicking links or opening attachments. If you believe this to be a malicious and/or phishing email, please send this email as an attachment to Cyber-Internal at sd-lecc.org<mailto:Cyber-Internal at sd-lecc.org>
________________________________
Dear Director King,
I am pleased to share with you the latest report from the Drug Threat Analysis Group, focusing on the analysis of fentanyl pill seizures across various HIDTA AORs from 2020 to 2023.
This report evaluates the trends in fentanyl pill seizures across the network of thirty-three HIDTAs in the United States, providing a detailed breakdown of changes observed over the specified period.
Key findings from the report include:

  *   Generally low to non-existent fentanyl pill seizures across most HIDTA AORs up to 2022.
  *   A noticeable seizure increase in the first quarter of 2023, followed by a decrease in the later quarters.
  *   Arizona was a significant outlier in 2023, with nearly twice the seizures of the next highest region.
  *   Higher prevalence of fentanyl pill seizures in the western AORs.
These insights are critical as they offer a comparative perspective that could enhance the strategies and responses of your HIDTA to the fentanyl pill issue. While this report concludes with data from the fourth quarter of 2023, it will be updated following the consolidation of the second quarter data for 2024 in July.
Don't hesitate to contact me with any questions or additional comments.
Thank you for your continued support.
Best regards,

J. David Hamby

National Coordinator

Drug Threat Analysis Group (DTAG)

National Strategic Analysis Initiative (NSAI)

High Intensity Drug Trafficking Areas (HIDTA)

(423) 344-1422​

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://sdtma.org/pipermail/members_sdtma.org/attachments/20240614/c83e23c9/attachment-0001.htm>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.png
Type: image/png
Size: 76877 bytes
Desc: image001.png
URL: <http://sdtma.org/pipermail/members_sdtma.org/attachments/20240614/c83e23c9/attachment-0003.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image002.png
Type: image/png
Size: 81700 bytes
Desc: image002.png
URL: <http://sdtma.org/pipermail/members_sdtma.org/attachments/20240614/c83e23c9/attachment-0004.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image003.png
Type: image/png
Size: 9263 bytes
Desc: image003.png
URL: <http://sdtma.org/pipermail/members_sdtma.org/attachments/20240614/c83e23c9/attachment-0005.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: Fentanyl Pills 0624.pdf
Type: application/pdf
Size: 2225551 bytes
Desc: Fentanyl Pills 0624.pdf
URL: <http://sdtma.org/pipermail/members_sdtma.org/attachments/20240614/c83e23c9/attachment-0001.pdf>